Melvin Sharoky MD - 17 Aug 2026 Form 4 Insider Report for INSMED Inc (INSM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Aug 2026, 16:10:19 UTC
Prior SEC filing
15 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melvin Sharoky, M.D, by Michael A. Smith as Attorney-in-fact

Key filing fact

Melvin Sharoky MD filed Form 4 for INSMED Inc (INSM) on 19 Aug 2026.

Key facts

  • This page summarizes Melvin Sharoky MD's Form 4 filing for INSMED Inc (INSM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Aug 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 15 May 2026.
  • Current net transaction value: -$637,650.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001182633 Primary reporting owner

SHAROKY MELVIN MD

Relationship
Director
Address
700 US HIGHWAY 202/206, BRIDGEWATER
Signature
/s/ Melvin Sharoky, M.D, by Michael A. Smith as Attorney-in-fact
Signature date
19 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM transaction

Common Stock

Sale

Transaction value
$637,650
Shares
-5,000
Change %
-100%
Price
$127.53
Shares after
0
Date
17 Aug 2026
Ownership
By Padonia, LLC
Footnotes
F1, F2
INSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
246,081
Date
17 Aug 2026
Ownership
Direct
INSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,847
Date
17 Aug 2026
Ownership
By spouse
INSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
819
Date
17 Aug 2026
Ownership
By Melvin Sharoky C/F Adler J. Wink UTMA/FL
Footnotes
F3
INSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,423
Date
17 Aug 2026
Ownership
By Melvin Sharoky C/F Nolan M. Wink UTMA/FL
Footnotes
F4
INSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,007
Date
17 Aug 2026
Ownership
By Melvin Sharoky C/F Sophie C. Wink UTMA/FL
Footnotes
F5
INSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,724
Date
17 Aug 2026
Ownership
By Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

This is the weighted average sales price representing 5,000 shares sold at prices ranging from $127.51 to $127.61 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Footnote F2

The Reporting Person is the managing member of Padonia, LLC.

Footnote F3

The Reporting Person is the custodian of Melvin Sharoky C/F Adler J. Wink UTMA/FL.

Footnote F4

The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL.

Footnote F5

The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

Footnote F6

The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .